Can Vigabatrin cure infantile spasms?

Vigabatrin has high efficacy in the treatment of infantile spasms (West syndrome) and is widely used in the management of the disease, but it cannot completely cure infantile spasms. Infantile spasms is a complex epileptic syndrome that usually presents in infancy and is characterized by paroxysmal muscle contractions and arrested development. Although the cause is complex and some children's condition may improve with age, the disease will still affect children's cognitive and neurological development.

Clinically, Vigabatrin is effective in treating infantile spasms, especially in cases related to tuberous sclerosis. Studies have shown that Vigabatrin can effectively reduce the frequency of seizures and improve the overall condition of some children. Its main mechanism of action is to increase the concentration of the inhibitory neurotransmitter GABA in the brain, thereby reducing abnormal discharge of neurons and controlling epileptic seizures. For some children, early standardized treatment may even improve the prognosis and quality of life to a certain extent.

However, Vigabatrin is not a cure. Most children require long-term management and close visual monitoring during treatment, as Vigabatrin may cause irreversible visual field loss. Doctors usually evaluate children's medication regularly and adjust the dosage or treatment plan based on effectiveness and tolerance. In addition, treatment of infantile spasms may involve other anti-epileptic drugs, hormone therapy, or surgery.

In short, Vigabatrin provides an effective treatment option for infantile spasms, but parents should work closely with doctors to ensure that the treatment is scientific and safe, hoping to control symptoms while laying the foundation for the long-term development of the child.